Color rolled out a preventive healthcare effort focused on high cholesterol and hereditary cancers, the Burlingame, Calif.-based genetic testing company announced May 6.
The initiative, dubbed Color Population Health, engages various hospitals nationwide to serve as launch partners. These hospitals will have the opportunity to offer patients full sequencing for genes associated with the CDC's Tier 1 genomic conditions, including hereditary breast cancer, ovarian cancer and nonpolyposis colorectal cancer, along with familial hypercholesterolemia. Color will also provide its launch partners with physician education support.
Color Population Health's launch partners include the Sidney Kimmel Cancer Center at Philadelphia-based Thomas Jefferson University, San Francisco-based UCSF Health and the University of Chicago Medicine.
Patients who undergo genetic testing through the Color Population Health program will have access to genetic counselors through Color or the participating hospitals, to help inform their understanding of genetic risks.
"The partnership with Color builds on our commitment to providing personalized cancer care," Stephen Klasko, MD, president and CEO of Jefferson Health and Thomas Jefferson University in Philadelphia, said in a May 6 statement. "We believe that this is a step toward offering preventative genomics responsibly to all patients across Jefferson Health."